{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-109814","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2026-09-23T11:30:41+00:00","discovered_at":"2026-09-23T11:35:01.946254+00:00","generated_at":"2026-09-23T11:35:14.288393+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CytoSorbents regains Nasdaq bid price compliance; MVLS delisting risk remains","bullets":["Regained compliance with Nasdaq Rule 5550(a)(2) after closing bid price held ≥$1.00 for 10 sessions ending Sept 21, 2026.","Still non-compliant with Rule 5550(b)(2) MVLS requirement: market value below $35M minimum; deadline Dec 28, 2026.","Company evaluating options, including raising stockholders' equity to at least $2.5M, to satisfy MVLS before deadline.","CEO reiterates priorities: operating cash flow breakeven in H2 2026, advancing DrugSorb-ATR toward FDA approval.","No assurance of regaining MVLS compliance or maintaining Nasdaq listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-109814","json":"https://secwatch.observer/filing/0001104659-26-109814.json","markdown":"https://secwatch.observer/filing/0001104659-26-109814.md","text":"https://secwatch.observer/filing/0001104659-26-109814.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465926109814/0001104659-26-109814-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465926109814/tm2625982d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-23T11:35:14.288393+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}